184 related articles for article (PubMed ID: 1704634)
1. Tumour markers in monitoring the treatment of advanced prostate cancer.
Cooper EH; Armitage TG
Prog Clin Biol Res; 1990; 359():65-72; discussion 73-4. PubMed ID: 1704634
[No Abstract] [Full Text] [Related]
2. [The role of PSA in prostatic adenocarcinoma].
Manca GP
Minerva Med; 1990 Apr; 81(4):261-4. PubMed ID: 1692981
[TBL] [Abstract][Full Text] [Related]
3. Prostate specific antigen and prostatic acid phosphatase measurements for the follow-up of patients with prostate cancer.
Mortarelli EA
Ann Clin Lab Sci; 1992; 22(4):201-6. PubMed ID: 1380223
[TBL] [Abstract][Full Text] [Related]
4. Cross-comparison of PSA and PAP values in a wide spectrum of prostate cancer conditions.
Tarle M
Anticancer Res; 1988; 8(4):569-72. PubMed ID: 2460018
[TBL] [Abstract][Full Text] [Related]
5. Laboratory studies for the detection of carcinoma of the prostate.
Brawer MK
Urol Clin North Am; 1990 Nov; 17(4):759-68. PubMed ID: 1699341
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of prostatic acid phosphatase and prostate-specific antigen in patients with prostatic cancer.
Pagani F; Zambolin T; Bonora R; Panteghini M
J Nucl Med Allied Sci; 1990; 34(4 Suppl):85-7. PubMed ID: 1709211
[TBL] [Abstract][Full Text] [Related]
7. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].
Akimoto S; Akakura K; Shimazaki J
Hinyokika Kiyo; 1988 Aug; 34(8):1389-96. PubMed ID: 2461644
[TBL] [Abstract][Full Text] [Related]
8. [Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate].
Morote Robles J; de Torres Mateos JA
Arch Esp Urol; 1989; 42 Suppl 2():124-30. PubMed ID: 2484148
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and pathological study of tumor marker in benign prostatic hypertrophy and incidental prostatic cancer].
Sakai N; Ogawa T; Ishibashi Y; Fukuoka H; Sakanishi S
Hinyokika Kiyo; 1991 Jun; 37(6):589-94. PubMed ID: 1716409
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma of the prostate. Serum tumour markers.
Ekman P
Scand J Urol Nephrol Suppl; 1991; 139():15-8. PubMed ID: 1722588
[TBL] [Abstract][Full Text] [Related]
11. [Prostatic diseases: tumor markers (PAP and PSA) and age at risk].
Manna A; Trasatti L; Cifaldi L; Marchei GG; Reale MG; Marchei P
J Nucl Med Allied Sci; 1990; 34(4 Suppl):91. PubMed ID: 1709213
[No Abstract] [Full Text] [Related]
12. Serum prostatic acid phosphatase activity and prostate specific antigen when the prostate gland is enlarged.
Jenkins D; Jones RT; Clarke AM
Med Lab Sci; 1991 Apr; 48(2):161-3. PubMed ID: 1719330
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
Bogdanowicz JF; Bentvelsen FM; Oosterom R; Schroeder FH
Scand J Urol Nephrol Suppl; 1991; 138():97-103. PubMed ID: 1723815
[TBL] [Abstract][Full Text] [Related]
14. Serum prostate-specific antigen: its use in diagnosis and management of prostate cancer.
Lange PH; Brawer MK
Urology; 1989 Jun; 33(6 Suppl):13-7. PubMed ID: 2471346
[No Abstract] [Full Text] [Related]
15. Prostate specific acid phosphatase versus five other possible tumour markers: a comparative study in men with prostatic carcinoma.
Larson A; Fritjofsson A; Norlén BJ; Gronowitz JS; Ronquist G
Scand J Clin Lab Invest Suppl; 1985; 179():81-8. PubMed ID: 2417306
[No Abstract] [Full Text] [Related]
16. [Prognostic factors in prostate cancer. Review of the literature and future perspectives].
Cussenot O; Ravery V; Desgrandchamps F; Cochand-Priollet B; Teillac P; Le Duc A
Prog Urol; 1994 Feb; 4(1):17-30. PubMed ID: 7514473
[No Abstract] [Full Text] [Related]
17. [Analysis of the serum concentration of prostate-specific antigen as a biological marker in the evolution of disseminated prostatic cancer].
Morote Robles J; de Torres Mateos JA; Soler-Roselló A
Actas Urol Esp; 1988; 12(2):152-7. PubMed ID: 2458015
[No Abstract] [Full Text] [Related]
18. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
Kuriyama M; Loor R; Wang MC; Lee C; Killian CS; Papsidero LD; Inaji H; Nishiura T; Slack NH; Murphy GP; Chu TM
Int Adv Surg Oncol; 1982; 5():29-49. PubMed ID: 6178696
[No Abstract] [Full Text] [Related]
19. Markers of undiagnosed incidental cancer in comparison with clinical prostatic cancer.
Ogawa A; Yoshida A; Kanda T; Sugihara S; Suzuki T; Tamura J; Kobayashi I; Nakazato Y
J Med; 2000; 31(1-2):101-10. PubMed ID: 10998759
[TBL] [Abstract][Full Text] [Related]
20. [Specific prostatic antigen: usefulness in clinical practice].
Isa Kroon WA; Sánchez de la Muela PL; Berian Polo JM
Med Clin (Barc); 1992 Mar; 98(9):345-7. PubMed ID: 1374824
[No Abstract] [Full Text] [Related]
[Next] [New Search]